Halozyme Therapeutics
HALO
#2060
Rank
ยฃ5.85 B
Marketcap
ยฃ47.51
Share price
0.02%
Change (1 day)
47.82%
Change (1 year)

Halozyme Therapeutics (HALO) - Cash on Hand

Cash on Hand as of December 2024 : ยฃ0.46 Billion

According to Halozyme Therapeutics's latest financial reports the company has ยฃ0.46 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Halozyme Therapeutics - Cash on Hand chart (from 2002 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ0.47 B80.1%
2023-12-31ยฃ0.26 B-12.05%
2022-12-31ยฃ0.29 B-45.37%
2021-12-31ยฃ0.54 B103.3%
2020-12-31ยฃ0.26 B-15.96%
2019-12-31ยฃ0.32 B15.02%
2018-12-31ยฃ0.27 B-19.55%
2017-12-31ยฃ0.34 B108.99%
2016-12-31ยฃ0.16 B127.23%
2015-12-31ยฃ73.1 M-16.08%
2014-12-31ยฃ87.11 M100.96%
2013-12-31ยฃ43.34 M-29.59%
2012-12-31ยฃ61.56 M81.13%
2011-12-31ยฃ33.98 M-36.98%
2010-12-31ยฃ53.93 M29.36%
2009-12-31ยฃ41.69 M-4.1%
2008-12-31ยฃ43.47 M-11.58%
2007-12-31ยฃ49.16 M117.95%
2006-12-31ยฃ22.56 M103.34%
2005-12-31ยฃ11.09 M33.06%
2004-12-31ยฃ8.33 M2861.91%
2003-12-31ยฃ0.28 M364.15%
2002-12-31ยฃ0.06 M236.58%
2001-12-31ยฃ0.01 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
ยฃ0.15 B-66.91%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.64 B 474.29%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.36 B 195.94%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ15.83 B 3,335.31%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ6.37 B 1,283.88%๐Ÿ‡ซ๐Ÿ‡ท France
ยฃ18.95 B 4,013.92%๐Ÿ‡บ๐Ÿ‡ธ USA